Regulation on the menu: Finding opportunity in a changing food system

The trade relationship between Canada and the United States has recently been making news and is among the largest in the world, with more than USD1 trillion in annual trade in goods and services. Agricultural and farm goods are always at the heart of discussions as the divide is philosophical. The US philosophy favours regulation in a free-market structure, while Canada sacrifices free market for income stability as found in the case of dairy farm quotas.

Regulatory differences affect competitivity. In the example of food additives, Canada generally requires pre-market approval by Health Canada before an additive may be used in food. The United States also regulates additives through the Food and Drug Administration (FDA), but permits the “Generally Recognized as Safe” (GRAS) framework, which allows ingredients to enter the market without the same formal review process. This has led to perceptions that Canada applies a more precautionary approach to food regulation. Small changes in regulations can affect farmer and grower profitability significantly.

The good news

North America is changing; dietary guidance in both Canada and the United States has shifted toward promoting whole foods and limiting highly processed foods. The next twenty years of food regulation may look much more like health-care regulation. Future regulators are increasingly likely to focus on metabolic health, chronic disease, nutritional quality and ingredient transparency. The food industry could experience a transformation similar to what happened with tobacco decades ago: not outright prohibition, but progressively tighter restrictions on ingredients perceived to contribute to long-term health costs. The resulting shift toward “food as medicine” may become one of the most important secular themes in agriculture, nutrition and health care.

Over the next decade, food safety regulators across the globe will increasingly focus on ultra-processed foods, food additives and dyes, sugar content, antibiotic use in livestock and nutritional labeling.

Raising the standards on raising proteins

These regulatory trends also apply to proteins, which are often affected by antibiotics and pesticide usage where regulations differ greatly by region.

As an example, Norway is generally considered the world’s most advanced and stringent salmon regulator. Amongst other measures, the country:

• Enforces strict sea-lice thresholds,
• Uses a “traffic-light” system that can limit industry growth if environmental impacts become excessive, and
• Explicitly incorporates wild salmon health into licensing decisions.

Norway has effectively said growth is permitted only if environmental performance improves.

These standards benefit companies that participate in the salmon industry via closed containment systems, sea-lice technologies, vaccines or aquaculture automation. This has allowed Norway to become the leading producer of high-quality salmon globally.

SalMar ASA (SALM NO) is the world’s second-largest Atlantic salmon producer. Headquartered in Frøya, Norway, the company operates a highly cost-efficient, vertically integrated aquaculture model spanning broodstock, smolt, ocean farming and processing. It sells to over 50 countries worldwide.

SalMar’s production footprint covers:

• Norway (Central & Northern): The foundational engine representing the vast majority of its volume.
• Iceland: Operates through its majority-owned subsidiary, Icelandic Salmon.
• Scotland: Runs a 50/50 joint venture via Scottish Sea Farms.
• SalMar Ocean: Its pioneering offshore and open-sea aquaculture division.

SalMar holds extensive unutilized capacity within its current operational licenses. Driven by exceptional biological performance (such as superior fish survival and growth rates), SalMar raised its full-year 2026 harvest guidance to 350,000 tonnes, marking a sharp 16% year-over-year volume increase from 2025. The company anticipates scaling this existing organic footprint further to reach 378,000 tonnes by 2028.

Agricultural pesticides

In agriculture, pesticide regulation can drastically affect the competitive landscape. This is evident when border regions grow similar produce such as California and Mexico.

Mexico has taken a strict stance against highly hazardous pesticides (HHPs). The country has banned over 180 pesticides that remain legally authorized in the United States, including systemic adjustments to phase out glyphosate. On the other side of the border, while California permits the use of certain chemicals banned in Mexico, it severely restricts how and when they can be applied (e.g., rigid tracking of drift, groundwater protection zones and strict worker re-entry intervals).

The California Department of Pesticide Regulation annual marketplace surveillance reports consistently shows that 97% to 98% of California-grown produce is completely compliant or features non-detectable residues. It is imported produce that dynamically accounts for a disproportionate volume of illegal pesticide residue violations.

For Mexican avocados and lemons to enter the US market legally, they must comply with US EPA pesticide residue tolerances. While Mexican avocados generally test clean because their thick, unconsumed skins shield the fruit, other Mexican citrus crops (like limes and lemons) occasionally trigger border enforcement actions due to traces of unapproved or excessive pesticides.

Global Alpha is invested in Limoneira Company (LMNR US), a diversified global agribusiness and land management corporation headquartered in Santa Paula, California.

Founded in 1893, they manage roughly 14,500 acres of agricultural land. Limoneira controls extensive global supply chains by sourcing citrus across the United States, Chile, South Africa and Mexico to ensure year-round supply for retail and foodservice buyers. Beyond pure farming, the company holds high-value, adjudicated water rights and operates a profitable real estate development arm.

Limoneira is undergoing a core business model transformation designed to unlock hidden asset value and shift capital into higher-margin segments.

Limoneira is aggressively shifting underutilized land into avocado production to capture robust, multiyear US demand growth. Avocado farming boasts superior unit economics over standard lemons. Driven by 400 acres planted in 2023 and 2024 finally reaching commercial maturation, management projected avocado production to exceed 10 million pounds in fiscal year 2027 – representing an ambitious 30% volume expansion. The company aims to add another 500 avocado acres by the end of 2027.

US trade case against Chinese choline

As food regulations increase, discrepancies between countries will multiply trade disputes and antidumping (AD) cases. In June 2026, a petition was filed alleging that Chinese producers were benefiting from Chinese government subsidies and dumping choline salts into the US market at unfairly low prices.

The U.S. Department of Commerce initiated AD and countervailing duty (CVD) investigations in July 2026, and the United States International Trade Commission (USITC) subsequently found a reasonable indication of injury to the US industry, allowing the investigations to proceed. The alleged dumping margins are substantial, ranging from 73% to over 300%. AD and CVD investigations are intended to protect US industries and workers from unfairly priced or subsidized imports as evidenced by this case regarding choline from China.

Choline is an essential nutrient used in poultry feed, swine feed, aquaculture, infant formula, human dietary supplements, functional foods and nutraceuticals.

Global Alpha participates in choline manufacturing through Balchem Corporation (BCPC US), a specialty ingredients company that operates at the intersection of nutritional science, microencapsulation technology and precise formulation.

Balchem focuses on niche markets where science-backed efficacy and stringent regulatory compliance allow for premium pricing, instead of competing as a bulk commodity supplier. The company is the global leader in choline production, dominating the market across both human and animal nutrition segments.

Rather than treating choline as a cheap bulk commodity, Balchem has spent over 50 years leveraging its proprietary manufacturing, purity testing and delivery technologies to command the leading global market share. The company’s revenue is diversified across three core business segments:

• Human nutrition & health (63% of revenue): High-margin specialty ingredients like branded choline, mineral amino acid chelates, vitamin K2 and texturizing systems used in dietary supplements, infant formula and functional foods.
• Animal nutrition & health (23% of revenue): Rumen-protected microencapsulated nutrients and choline delivery mechanisms that optimize health and milk production in dairy cattle and livestock.
• Specialty products (14% of revenue): High-purity gases and packaged chemicals used primarily in medical device sterilization, agricultural fumigation and plant micronutrient delivery.

As regulation continues to reshape agricultural costs and competitiveness, locally focused producers with resilient supply chains may be best positioned to manage inflationary pressures – a thematic we continue to follow closely at Global Alpha.